High-throughput screening for small-molecule modulators of inward rectifier potassium channels

Area of Science:

• Molecular Pharmacology
• Ion Channel Physiology
• Assay Development

Background:

• Inward rectifier potassium (Kir) channels are key drug targets for cardiovascular and pain disorders, but their study is hindered by a lack of effective pharmacological tools.
• Existing peptide inhibitors, like tertiapin, have limitations for therapeutic and experimental use due to poor bioavailability and immunogenicity.
• The development of small-molecule probes is essential for advancing Kir channel research and understanding their physiological roles and therapeutic potential.

Purpose of the Study:

• To describe the development of a robust fluorescence-based thallium (Tl+) flux assay for high-throughput screening (HTS) of Kir channel modulators.
• To provide a method amenable for academic scientists seeking entry into the National Institutes of Health (NIH) Molecular Libraries Probes Production Center Network (MLPCN).
• To establish performance benchmarks for assay validation and potential MLPCN inclusion.

Main Methods:

• Utilized a fluorescence-based assay employing a thallium (Tl+) reporter dye (FluoZin-2) to measure Tl+ flux across cell membranes.
• The assay leverages the permeability of Kir channels to Tl+, a potassium congener, detected by a change in fluorescence.
• Protocol details assay development steps applicable to commercially available Tl+ dyes like BTC, FluoZin-2, and FluxOR.

Main Results:

• Successfully developed a fluorescence-based Tl+ flux assay suitable for HTS of Kir channel activity.
• Demonstrated that FluoZin-2 provides a robust and dose-dependent fluorescence increase upon Tl+ binding, enabling reliable flux measurements.
• The assay is adaptable to various potassium (K+) channels due to Tl+'s broad permeability across these channels.

Conclusions:

• The developed Tl+ flux assay is a critical tool for discovering novel small-molecule inhibitors and activators of Kir channels.
• This assay facilitates the identification of much-needed pharmacological probes to advance the understanding of Kir channel physiology and disease relevance.
• The assay protocol and performance benchmarks provide a pathway for researchers to access resources for developing chemical probes for under-explored targets.